Breast Cancer, D'Antona (Europa Donna): "With Targeted Genomic Therapy Test"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.9 Articles
9 Articles
Il Tempo
Rome, 9 Sep. (Adnkronos Salute) - "In the past, in 30% of cases women faced a chemotherapy treatment that unfortunately proved useless. Today, however, thanks to the genomic test "the number of unnecessary chemotherapy has been drastically reduced." This is because, "once performed the test, the pathologist indicates whether or not there is the need to undergo the treatment. In our opinion it is essential to include these tests in the Lea, the e…
(Adnkronos) - "After a first phase of information on the importance of genomic tests in breast cancer addressed to associations that are part of Europa Donna, we worked alongside clinicians and societies...
(Adnkronos) "In the past, in 30% of cases women faced a chemotherapy treatment that unfortunately proved useless. Today, however, thanks to the " genomic" test "the number of unnecessary chemotherapy has been drastically reduced." This is because, "once the test was carried out, the pathologist indicates whether or not there is a need to undergo [...]
notizie.it
Rec News | Lontani dal mainstream(Adnkronos) - “In the past, in 30% of cases, women faced chemotherapy treatment that unfortunately proved useless. Today, however, thanks to the
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
